Continuous glucose monitoring, insulin pumps, closed-loop systems, and digital tools in diabetes care.
In insulin-treated type 2 diabetes, automated insulin delivery reduced HbA1c by an adjusted 0.6 percentage points and increased time in range by 14 points versus CGM with usual insulin delivery.
A multicentre randomised trial testing a CBT-based WeChat dietary programme against standard care for postprandial glucose and pregnancy outcomes in gestational diabetes. PICO summary and expert commentary.
A manufacturer-sponsored secondary analysis found a digital diabetes logbook nearly doubled the odds of reaching HbA1c 6.5% or below at 3 months, with associated real-world glucose reductions. PICO summary and expert commentary.
An RCT finds Bluetooth glucometers match traditional meters on HbA1c during telehealth insulin titration but cut ED visits. PICO summary and expert commentary for clinicians.
An open RCT finds a smart-speaker virtual assistant with a behavioural intervention reduces mental distress and improves quality of life, self-care, and HbA1c in older adults with type 2 diabetes. PICO summary and commentary.
A large international RCT finds automated insulin delivery (MiniMed 670G/770G) improves HbA1c in those above 8% and reduces hypoglycaemia in those at target versus multiple daily injections in type 1 diabetes. PICO summary and commentary.
A 24-week RCT finds Bluetooth-enabled glucometers do not improve glucose control over traditional glucometers in telehealth insulin titration, though they reduce emergency department visits. PICO summary and commentary.
A pilot study finds a computer-vision food-photo app estimates energy intake about as well as 24-hour recall, but both underestimate true intake versus measured expenditure. PICO summary and commentary.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
© 2024-2026 Hormone Insight. All rights reserved.
